2021
DOI: 10.1016/b978-0-12-819814-8.00014-7
|View full text |Cite
|
Sign up to set email alerts
|

Neurologic complications of genetic channelopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Therefore, they are amenable to addressing focused questions about how pathological conditions that alter specific molecules (ion channels, receptors) confined to certain neuronal subtypes affect continuous attractor networks and associated behavioral outcomes. As synaptopathies and channelopathies are strongly associated with several neurological disorders (Kullmann, 2002; Terzic and Perez-Terzic, 2010; Grant, 2012; Poolos and Johnston, 2012; Lerche et al, 2013; Brager and Johnston, 2014; Mandolesi et al, 2015; Rivolta et al, 2020; Deng and Klyachko, 2021; Franklin and Laubham, 2021; Kessi et al, 2021; Mantegazza et al, 2021), this ability to assess the heterogeneous impact of altering specific components is invaluable from a theoretical perspective as well as from the perspective of designing specific experiments or drug targets. The process outlined here to generate heterogeneous networks could also be employed to build heterogeneous neurons and networks that mimic the several differences that are observed under specific pathological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, they are amenable to addressing focused questions about how pathological conditions that alter specific molecules (ion channels, receptors) confined to certain neuronal subtypes affect continuous attractor networks and associated behavioral outcomes. As synaptopathies and channelopathies are strongly associated with several neurological disorders (Kullmann, 2002; Terzic and Perez-Terzic, 2010; Grant, 2012; Poolos and Johnston, 2012; Lerche et al, 2013; Brager and Johnston, 2014; Mandolesi et al, 2015; Rivolta et al, 2020; Deng and Klyachko, 2021; Franklin and Laubham, 2021; Kessi et al, 2021; Mantegazza et al, 2021), this ability to assess the heterogeneous impact of altering specific components is invaluable from a theoretical perspective as well as from the perspective of designing specific experiments or drug targets. The process outlined here to generate heterogeneous networks could also be employed to build heterogeneous neurons and networks that mimic the several differences that are observed under specific pathological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, there are reports of changes to ion-channel properties and intrinsic properties spanning different neuronal subtypes under several pathophysiological and altered behavioral conditions (Kullmann and Waxman, 2010; Terzic and Perez-Terzic, 2010; Cannon, 2021; Deng and Klyachko, 2021; Franklin and Laubham, 2021; Gripp et al, 2021; Kessi et al, 2021; Mantegazza et al, 2021). Thus, future studies should explore the impact of altered channel properties/densities under different behavioral and pathological conditions on specific ion channels and the physiology of SCN neurons, as well as the impact on transitions and plasticity manifolds associated with them.…”
Section: Discussionmentioning
confidence: 99%